When Berkshire Hathaway divests from processed foods, it signals a massive shift that smart investors are already positioning for. The writing is on the wall for legacy food brands.
Consumer spending on natural, organic, and wellness products is accelerating rapidly. These companies are perfectly positioned to capture this multi-billion pound market transformation.
These carefully selected companies aren't just riding the health trend - they're leading it. From plant-based innovations to private-label dominance, they're defining tomorrow's grocery aisle today.
Berkshire Hathaway's divestment from Kraft Heinz signals a major shift away from legacy processed foods. This creates opportunities for companies aligned with modern consumer preferences for healthier, natural, and private-label alternatives that are reshaping the grocery industry.
This group spans the evolving food value chain, from natural food distributors to specialty grocers and wellness product manufacturers. These companies are positioned to benefit from the long-term consumer pivot towards healthier eating habits and transparent food sourcing.
Each company was carefully selected by professional analysts for its strategic position in the modern grocery transformation. They represent businesses that are capturing market share as consumers and influential investors move away from traditional processed food models.
Berkshire Hathaway's plan to sell its major stake in Kraft Heinz signals a larger market trend against legacy packaged foods. This creates an investment opportunity in companies better aligned with modern consumer demands for healthier and private-label options.
The basket's total market capitalisation is 42,651.61, with a few large-cap stocks anchoring most of the weighting. That concentration tends to make the basket relatively stable and more reflective of broad-market behaviour than speculative growth.
UNFI: $2.07B
SFM: $7.06B
THS: $1.23B
+5
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Here are a few of the assets in this group. Create an account to unlock the full list.
On average, analysts expect assets in this group to grow 88.7% over the next year.
12 of 14 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+88.70%
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
